Israel’s BioBeat (see here previously) has just completed a study of its wearable chest monitor in use on 521 patients. It reported a 77% success rate for detecting those at high risk of deterioration. This compared with 20% monitored using current alternative methods.
https://nocamels.com/2023/03/wireless-device-monitors-patients-vital-signs/
https://www.frontiersin.org/articles/10.3389/fphys.2023.1138647/full